CIBUS INC (CBUS) Stock Fundamental Analysis

NASDAQ:CBUS • US17166A1016

3.69 USD
+0.17 (+4.83%)
At close: Feb 27, 2026
3.6 USD
-0.09 (-2.44%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

CBUS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 520 industry peers in the Biotechnology industry. Both the profitability and financial health of CBUS have multiple concerns. CBUS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CBUS had negative earnings in the past year.
  • CBUS had a negative operating cash flow in the past year.
  • In the past 5 years CBUS always reported negative net income.
  • In the past 5 years CBUS always reported negative operating cash flow.
CBUS Yearly Net Income VS EBIT VS OCF VS FCFCBUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

  • CBUS has a better Return On Assets (-36.01%) than 60.54% of its industry peers.
  • With a Return On Equity value of -235.91%, CBUS is not doing good in the industry: 70.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -36.01%
ROE -235.91%
ROIC N/A
ROA(3y)-65.46%
ROA(5y)-69.14%
ROE(3y)-199.52%
ROE(5y)-185.43%
ROIC(3y)N/A
ROIC(5y)N/A
CBUS Yearly ROA, ROE, ROICCBUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

  • CBUS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBUS Yearly Profit, Operating, Gross MarginsCBUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • CBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CBUS has been increased compared to 1 year ago.
  • The number of shares outstanding for CBUS has been increased compared to 5 years ago.
  • The debt/assets ratio for CBUS has been reduced compared to a year ago.
CBUS Yearly Shares OutstandingCBUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CBUS Yearly Total Debt VS Total AssetsCBUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -3.66, we must say that CBUS is in the distress zone and has some risk of bankruptcy.
  • CBUS has a Altman-Z score (-3.66) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that CBUS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, CBUS is in line with its industry, outperforming 49.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.66
ROIC/WACCN/A
WACC8.6%
CBUS Yearly LT Debt VS Equity VS FCFCBUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 1.28 indicates that CBUS should not have too much problems paying its short term obligations.
  • The Current ratio of CBUS (1.28) is worse than 82.95% of its industry peers.
  • A Quick Ratio of 1.28 indicates that CBUS should not have too much problems paying its short term obligations.
  • CBUS has a worse Quick ratio (1.28) than 82.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CBUS Yearly Current Assets VS Current LiabilitesCBUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CBUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.01%, which is quite impressive.
  • Looking at the last year, CBUS shows a decrease in Revenue. The Revenue has decreased by -8.64% in the last year.
  • The Revenue for CBUS have been decreasing by -10.20% on average. This is quite bad
EPS 1Y (TTM)82.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-833.33%
Revenue 1Y (TTM)-8.64%
Revenue growth 3Y-45.26%
Revenue growth 5Y-10.2%
Sales Q2Q%-63.11%

3.2 Future

  • CBUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.85% yearly.
  • The Revenue is expected to grow by 107.38% on average over the next years. This is a very strong growth
EPS Next Y9.85%
EPS Next 2Y22.63%
EPS Next 3Y16.12%
EPS Next 5Y20.85%
Revenue Next Year-2.2%
Revenue Next 2Y39.55%
Revenue Next 3Y59.92%
Revenue Next 5Y107.38%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CBUS Yearly Revenue VS EstimatesCBUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
CBUS Yearly EPS VS EstimatesCBUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CBUS. In the last year negative earnings were reported.
  • Also next year CBUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBUS Price Earnings VS Forward Price EarningsCBUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBUS Per share dataCBUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CBUS's earnings are expected to grow with 16.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.63%
EPS Next 3Y16.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CBUS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CIBUS INC

NASDAQ:CBUS (2/27/2026, 8:00:02 PM)

After market: 3.6 -0.09 (-2.44%)

3.69

+0.17 (+4.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)03-19
Inst Owners21.51%
Inst Owner Change4.15%
Ins Owners30.16%
Ins Owner Change5.91%
Market Cap250.55M
Revenue(TTM)3.79M
Net Income(TTM)-118.90M
Analysts80
Price Target14.59 (295.39%)
Short Float %3.42%
Short Ratio5.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.66%
Min EPS beat(2)13.74%
Max EPS beat(2)17.57%
EPS beat(4)2
Avg EPS beat(4)2.11%
Min EPS beat(4)-12.97%
Max EPS beat(4)17.57%
EPS beat(8)3
Avg EPS beat(8)-86.86%
EPS beat(12)4
Avg EPS beat(12)-138.03%
EPS beat(16)8
Avg EPS beat(16)-94.55%
Revenue beat(2)0
Avg Revenue beat(2)-38.42%
Min Revenue beat(2)-56.66%
Max Revenue beat(2)-20.19%
Revenue beat(4)1
Avg Revenue beat(4)-20.71%
Min Revenue beat(4)-56.66%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)48.49%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.69%
PT rev (3m)-0.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-11.05%
EPS NY rev (3m)-2.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)-17.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 66.04
P/FCF N/A
P/OCF N/A
P/B 4.97
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.66
EYN/A
EPS(NY)-1.52
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0.06
BVpS0.74
TBVpS-3.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.01%
ROE -235.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-65.46%
ROA(5y)-69.14%
ROE(3y)-199.52%
ROE(5y)-185.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.76%
Cap/Sales 14.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z -3.66
F-Score5
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)67.73%
Cap/Depr(5y)64.06%
Cap/Sales(3y)402.26%
Cap/Sales(5y)243.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-833.33%
EPS Next Y9.85%
EPS Next 2Y22.63%
EPS Next 3Y16.12%
EPS Next 5Y20.85%
Revenue 1Y (TTM)-8.64%
Revenue growth 3Y-45.26%
Revenue growth 5Y-10.2%
Sales Q2Q%-63.11%
Revenue Next Year-2.2%
Revenue Next 2Y39.55%
Revenue Next 3Y59.92%
Revenue Next 5Y107.38%
EBIT growth 1Y7.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.52%
EBIT Next 3Y29.41%
EBIT Next 5Y22.66%
FCF growth 1Y-40.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.43%
OCF growth 3YN/A
OCF growth 5YN/A

CIBUS INC / CBUS FAQ

Can you provide the ChartMill fundamental rating for CIBUS INC?

ChartMill assigns a fundamental rating of 2 / 10 to CBUS.


What is the valuation status of CIBUS INC (CBUS) stock?

ChartMill assigns a valuation rating of 0 / 10 to CIBUS INC (CBUS). This can be considered as Overvalued.


Can you provide the profitability details for CIBUS INC?

CIBUS INC (CBUS) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CBUS stock?

The Earnings per Share (EPS) of CIBUS INC (CBUS) is expected to grow by 9.85% in the next year.